Patents
Patents for C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton (11,541)
03/2000
03/22/2000CN1248240A Process for preparing N, N, N', N'-tetra-(2-hydroxyethyl) ethylenediamine
03/22/2000CN1050598C Novel method for producing para-aminophenol
03/21/2000US6040482 Produced in a single step by reacting an oxyalkylene oxide or oxyalkylester having from 3 to 12 carbon atoms, glycidol, or a glycidyl with an aminophenol without the use of a catalyst and at low temperatures; xanthene, coumarin dyes
03/21/2000US6040480 Preparing 2-(1,1,1-trifluoro-2-hydroxy-4-cyclopropyl-but-3-yn-2-yl),4-chloroaniline; cyclization; human immunodeficiency virus (hiv) reverse transcriptase inhibitor nontoxic maaterials; nonchromagraphic purification
03/21/2000US6040464 Reacting a protected 1,2-dihydroxybutryamide in a hoffman rearrangement reaction mixture comprising a hypohalite, a base and solvent; chiral chemical intermediates: drugs, beta-blockers, phospholipids, liquid crystals
03/16/2000WO1999043636A3 Disubstituted lavendustin a analogs and pharmaceutical compositions comprising the analogs
03/15/2000CN1247535A Aminoepoxides from aminoaldehydes and in-situ formed halomethyl organometallic reagent
03/14/2000US6037505 Enantioselective oxazaborolidine catalysts
03/14/2000US6037364 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
03/09/2000WO2000012462A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
03/09/2000WO2000012461A1 Process for making 2-amino-5-cyanophenol
03/09/2000CA2341711A1 Process for making 2-amino-5-cyanophenol
03/09/2000CA2341458A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
03/08/2000EP0983995A2 Pharmaceutically-active dimethyl-(3-aryl-but-3-enyl)-amine compounds
03/08/2000EP0983994A2 Pharmaceutically-active dimethyl-(3-aryl-but-3-enyl)-amine compounds
03/08/2000CN1246844A Process for preparation of iodinated contrast agents and intermediates
03/07/2000US6034277 Process for the preparation of 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene derivatives
03/07/2000US6034242 2,4-pentadienoic acid derivatives having retinoid-like biological activity
03/02/2000WO1999042460A9 Process for the production of optically enriched (r)- or (s)-albuterol
03/01/2000EP0981520A1 Efficient enantioselective addition reaction using an organozinc reagent
02/2000
02/29/2000US6031135 Protein kinase-c activity; antitumor agents, antiinflammatory agents, preservatives; treating thrombosis
02/29/2000US6031134 Process for the preparation of 2-amino-2-arylethanols and novel intermediates
02/29/2000US6031003 Calcium receptor-active molecules
02/24/2000WO2000009517A2 Process for the preparation of n-(phosphonomethyl)glycine by oxidizing n-substituted n-(phosphonomethyl)glycine
02/24/2000WO2000009475A1 Amine derivatives
02/24/2000CA2339634A1 Amine derivatives
02/23/2000CN1245164A Echcin and its fermenting extraction process
02/23/2000CN1245162A Process for preparing amine
02/22/2000US6028227 Contacting a mixture of nitrobenzene and water with hydrogen over a solid acid catalyst, solvent extraction, separating the aqueous layer containing the product, concentrating the aqueous layer to obtain the product
02/22/2000US6028224 Fluoxetine process from benzoylpropionic acid
02/22/2000US6028217 Chemical intermediate for renin inhibitor or enkephalinase enzyme inhibitor
02/22/2000US6028193 Catalyzing the oxidation reaction in presence of a transition metal complex which contains a cyclic polyfunctional amine compound having at least three nitrogen atoms in the ring forming molecular
02/22/2000US6028132 Resinous material containing quaternary ammonium salt
02/22/2000US6028103 Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation
02/18/2000CA2280455A1 The use of aryl-cyclohexylamine derivatives against cns disorders
02/17/2000WO2000008031A1 Novel phospholipids with unsaturated alkyl and acyl chains
02/17/2000WO2000007976A1 Fluoxetine process from benzoylacetonitrile
02/17/2000WO2000007709A1 Pesticide formulations containing alkoxylated amine neutralized aromatic sulfonic acid surfactants
02/15/2000US6025517 Fluoxetine process from benzoylacetonitrile
02/15/2000US6025177 Asymmetric grignard synthesis with cyclic 1,2 aminoalcohols
02/15/2000US6024768 Diaminoalkane and oxidation colorants
02/10/2000WO2000006658A2 Adhesives and sealants
02/10/2000WO2000006610A2 Polymer production
02/10/2000WO2000006585A1 Medicine nitrate salts
02/10/2000WO2000006531A2 Nitric esters and nitrate salts of specific drugs
02/10/2000WO2000006137A2 Glucocorticoid-selective anti-inflammatory agents
02/10/2000WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors
02/10/2000DE19835611A1 Neuartige Phospholipide mit synthetischen, ungesättigten Alkyl- und Acylketten Novel synthetic phospholipids with unsaturated alkyl and acyl chains
02/10/2000DE19829515A1 Metal-modified zeolite catalyst for the hydroxylation of aromatics with nitrous oxide, obtained by treatment of zeolite with gaseous metal salt, e.g. iron-III chloride, followed by calcination at high temperature
02/10/2000CA2338912A1 Medicine nitrate salts
02/09/2000EP0978512A1 Non-imidazole aryloxy (or arylthio) alkylamines as histamine H3-receptor antagonists and their therapeutic applications
02/09/2000CN1243971A Alkoxyl N-hydroxy alkyl acylamine used as corrosion inhibitor remover
02/08/2000US6022996 Method for making intermediates useful in synthesis of retroviral protease inhibitors
02/08/2000US6022995 Process for the preparation of 2-amino-2-arylethanols and novel intermediates
02/08/2000US6022895 Substituted amino compounds and their use as substances having an analgesic effect
02/03/2000WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors
02/03/2000WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors
02/02/2000EP0976720A1 Propanolamine derivatives
02/02/2000EP0975581A1 Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine choline tartrate
02/02/2000EP0975560A1 Chiral separations of amino acids
02/01/2000US6020527 Stereospecific isomerisation of allyl amines using chiral phosphorous ligands
02/01/2000US6020523 Polyorganofullerenes
01/2000
01/27/2000WO1999063930A3 Novel angiotensin receptor modulators and their uses
01/26/2000EP0973763A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
01/26/2000EP0973755A1 Asymmetric synthesis of benzoxazinones via new intermediates
01/26/2000EP0973724A1 Novel process for the preparation of (+/-)3- (3,4-dichlorophenyl)-2- dimethylamino-2-methylpropan-1-ol or cericlamine (inn)
01/26/2000EP0973723A1 A process for the preparation of an aminoalcohol
01/26/2000CN1242358A Process for prepn. of optically pure aminoalcohol
01/25/2000US6018069 (2s,3s,5s)-2,5-diamine-1,6-diphenyl-3-hydroxyhexane compounds are purified by obtaining the acid addition salt from a mixture with its (2s,3s,5r) stereoisomer; useful as intermediates to hiv protease inhibitor synthesis
01/25/2000US6017965 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
01/25/2000US6017928 Retroviral protease inhibiting compounds
01/25/2000CA2146903C Reductive amination catalysts for the selective production of aminoethylethanolamine
01/20/2000WO1999059527A3 Oxidizing hair coloring agents containing 2,5-diamino-1-phenylbenzene derivatives and novel 2,5-diamino-1-phenylbenzene derivatives
01/19/2000EP0972764A1 Aminoalcohols and aminoketones as CNS active agents
01/19/2000EP0971885A1 Process for preparing indane-like compounds
01/19/2000CN1048498C Enantioselective 1, 3, 2-oxazaborolidine catalysts
01/18/2000US6015926 Adding dialkylzinc to chiral additive, adding second additive to form chiral zinc complex, mixing with organometallic reagent, reacting with carbonyl compound to form desired alcohol
01/18/2000US6015903 Method of resolving racemic mixtures
01/18/2000US6015899 Low volatility additives which give heat, oxidation and light resistance to plastics
01/18/2000US6015819 Administering adrenergic blocking agent; reduction of orthostatic fall in blood pressure side effect; fda orange book listed patent for silodosin
01/13/2000WO2000001659A1 Phenalkylamine derivatives, their use as curing agents in epoxy resin compositions and curable epoxy resin compositions containing them
01/12/2000EP0970066A1 Aminoepoxides from aminoaldehydes and in-situ formed halomethyl organometallic reagent
01/12/2000EP0970042A1 5-hydroxymethyl-2-aminotetralins as cardiovascular agents
01/12/2000EP0970041A1 New diaminoalkane and oxidation dyeing agent
01/11/2000US6013830 Chemical intermediates for oxybutynin, oxyphencyclimine, oxyphenonium bromide, oxypyrronium bromide, and oxysonium iodide, for which cyclohexylphenylglycolic acid (chpga) is of special interest; stereoselectivity
01/11/2000US6013801 Method for producing aminoethylethanolamine and/or hydroxyethyl piperazine
01/06/2000WO2000000459A1 Process for the preparation of optically active trans-cyclohexylamine compounds
01/05/2000EP0968173A1 Process for the preparation of iodinated contrast agents and intermediates therefor
01/05/2000EP0968172A1 Process for preparing n,n,n',n'-tetra-(2-hydroxyethyl)ethylenediamine
01/05/2000EP0968171A1 Novel cationic oxidation bases, their use for oxidation dyeing of keratin fibres, dyeing compositions and dyeing methods
01/05/2000CN1240419A Aromatic amine derivatives having NOS inhibitory effect
01/04/2000US6011154 Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present
01/04/2000US6011068 Carbocyclic-alkyl secondary amines
01/04/2000US6010289 Locking nut, bolt and clip systems and assemblies
12/1999
12/29/1999WO1999067231A1 Nitrate salts of antihypertensive medicines
12/29/1999WO1999067198A1 Desformoterol and process for its preparation
12/29/1999WO1999067197A1 Benflumetol derivatives, intermediates thereof and their use against parasitical protozoa and trematodes
12/29/1999WO1999067196A1 Fluoxetine process from benzoylpropionic acid
12/29/1999WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors
12/29/1999EP0966423A1 Hydroxymethyl derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene as cardiovascular agent
1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 116